The company has significantly advanced the development of an innovative treatment for amyloid heart disease, utilizing Attruby. Early trial data indicates significant outcomes for patients suffering from the debilitating condition. This focus represents researchers’ commitment to addressing unmet healthcare needs in a heart disease field. Attrub